According to Merck's latest financial reports the company's total assets are $115.12 Billion USD. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | $117.10 B | 9.78% |
2023-12-31 | $106.67 B | -2.28% |
2022-12-31 | $109.16 B | 3.28% |
2021-12-31 | $105.69 B | 15.4% |
2020-12-31 | $91.58 B | 8.52% |
2019-12-31 | $84.39 B | 2.13% |
2018-12-31 | $82.63 B | -5.96% |
2017-12-31 | $87.87 B | -7.87% |
2016-12-31 | $95.37 B | -6.2% |
2015-12-31 | $101.67 B | 3.58% |
2014-12-31 | $98.16 B | -7.08% |
2013-12-31 | $105.64 B | -0.46% |
2012-12-31 | $106.13 B | 0.96% |
2011-12-31 | $105.12 B | -0.62% |
2010-12-31 | $105.78 B | -5.82% |
2009-12-31 | $112.31 B | 137.98% |
2008-12-31 | $47.19 B | -2.39% |
2007-12-31 | $48.35 B | 8.48% |
2006-12-31 | $44.56 B | -0.62% |
2005-12-31 | $44.84 B | 5.34% |
2004-12-31 | $42.57 B | 4.89% |
2003-12-31 | $40.58 B | -14.66% |
2002-12-31 | $47.56 B | 8.04% |
2001-12-31 | $44.02 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $208.02 B | 80.70% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $193.67 B | 68.23% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $89.38 B | -22.35% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $92.42 B | -19.71% | ๐บ๐ธ USA |
![]() Sanofi SNY | $142.69 B | 23.95% | ๐ซ๐ท France |
![]() GlaxoSmithKline GSK | $78.43 B | -31.87% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $38.41 B | -66.63% | ๐ฎ๐ฑ Israel |
![]() Novartis NVS | $99.94 B | -13.19% | ๐จ๐ญ Switzerland |
![]() Abbott Laboratories ABT | $81.44 B | -29.25% | ๐บ๐ธ USA |
![]() Amgen AMGN | $89.36 B | -22.37% | ๐บ๐ธ USA |